A Study of RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to Methotrexate

NCT01587989 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: methotrexate
DRUG: methotrexate
DRUG: placebo
DRUG: tocilizumab [RoActemra/Actemra]

Sponsor

Hoffmann-La Roche